Results 241 to 250 of about 67,058 (255)

Trisomy 8 Involved in Myelodysplastic Syndromes as a Risk Factor for Intestinal Ulcers and Thrombosis — Behçet's Syndrome

Leukemia and Lymphoma, 2001
Junya Kuroda, Shinya Kimura, Teruaki Akaogi   +2 more
exaly  

Myelodysplastic syndrome and associated skin lesions: a review of the literature

Leukemia Research, 1999
Irit Avivi, Jacob Rowe, Yishai Levy
exaly  

Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia

Nature Genetics, 2011
Christopher N Hahn, Chan Eng Chong, Marshall Horwitz   +2 more
exaly  

EED mutants impair polycomb repressive complex 2 in myelodysplastic syndrome and related neoplasms

Leukemia, 2012
Honda H, Inaba T, Sanada M
exaly  

Myelodysplastic Syndrome Associated with Bone Marrow Fibrosis

Leukemia and Lymphoma, 1992
A Oriani, D Soligo, C Annaloro
exaly  

SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function

Cell Stem Cell, 2018
Ravi Bhatia, Ling Li
exaly  

TREATMENT FOR MYELODYSPLASTIC SYNDROMES

The Lancet, 1987
A, Pagliuca, D M, Layton, G J, Mufti
openaire   +2 more sources

Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q)

Blood Cancer Journal, 2014
Pierre Fenaux, Guillermo Sanz, Mikkael Sekeres   +2 more
exaly  

TP53 Mutations in Myelodysplastic Syndrome

Leukemia and Lymphoma, 1996
Shigeo Horiike, Shinichi Misawa, S Horiike   +2 more
exaly  

Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome

Leukemia, 2012
Mikkael Sekeres, Parmar S, Kantarjian H   +2 more
exaly